Lymph node dissection during radical cystectomy for bladder cancer treatment: Considerations on relevance and extent

International Urology and Nephrology

Volumn 45, Issue 6, 2013, Pages 1561-1567

  Weisbach, Lars ^a   Dahlem, Roland ^a   Simone, Giuseppe ^b   Hansen, Jens ^a   Soave, Armin ^a   Engel, Oliver ^a   Chun, Felix K ^a   Shariat, Shahrokh F ^c   Fisch, Margit ^a   Rink, Michael ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bladder cancer; Lymphadenectomy; Prognosis; Prognostic models; Survival; Urothelial carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BLADDER CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; HUMAN; INCONTINENCE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; LYMPHOCELE; MICROMETASTASIS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; RECURRENCE FREE SURVIVAL; REVIEW; SENTINEL LYMPH NODE; TRANSITIONAL CELL CARCINOMA;

CARCINOMA; CYSTECTOMY; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; RISK ASSESSMENT; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 84890802840     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0503-2     Document Type: Review

References (55)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer Statistics 2013. CA Cancer J Clin 63(1):11-30
2. Ferlay J, Shin HR et al (2010) Estimates of worldwide burden of cancer in 2008: globocan 2008. Int J Cancer 127:2893-2917
3. Shariat SF, Palapattu GS, Amiel GE et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176(6 Pt 1):2414-2422
4. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19:666-675
5. Madersbacher S et al (2003) Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 21(4):690-696
6. Shariat SF, Rink M, Ehdaie B et al (2013) Pathological nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Eur Urol 63:371-378
7. Kassouf W, Svatek RS, Shariat SF et al (2013) Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of the bladder. Urol Oncol 31(4):480-486
8. Rink M, Hansen J, Cha E, Shariat SF et al (2013) Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int 111(1):74-84
9. Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF (2009) Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol 182:2182-2187
10. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295-1298
11. Karl A, Carroll PR, Gschwend JE et al (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55:826-835
12. Konety BR, Joslyn SA, O' Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, epidemiology and end results program data base. J Urol 169:946-950
13. Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE (2001) Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166:19-23
14. Stein JP, Cai J, Groshen S, Skinner DG (2003) Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170:35-41
15. Vieweg J, Gschwend JE, Herr HW, Fair WR (1999) The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 161:72-76
16. Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA (2010) European Association of Urology. Update of the clinical guidelines of the European Association of Urology on muscle invasive and metastatic bladder carcinoma. Actas Urol Esp 34:51-62
17. Shariat SF, Palapattu GS, Karakiewicz PI et al (2007) Discrepancy between clinical and pathological stage: impact on prognosis after radical cystectomy. Eur Urol 51:137-151
18. Cowan NC, Crew JP (2010) Imaging bladder cancer. Curr Opin Urol 20:409-413
19. Sherif A, Garske U, de la Torre M, Thörn M (2006) Hybrid SPECT-CT:an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 50:83-91
20. Liedberg F, Chebil G, Davidsson T, Gudjonnson S, Mansson W (2006) Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol 175:84-88
21. Machtens S, Serth J, Meyer A, Kleinhorst C, Ommer KJ, Herbst U, Kieruij M, Boerner AR (2007) Positron emission tomography (PET) in the urooncological evaluation of the small pelvis. World J Urol 4:341-349
22. Bellin MF, Roy C (2007) Magnetic resonance lymphography. Curr Opin Urol 17:65-69
23. Stenzl A, Cowan NC, De Santis M et al (2011) Treatment of muscle invasive and metastatic bladder cancer: update of the EAU Guidelines. Eur J Urol 59:1009-1018
24. Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128:34-36
25. Dorin RP, Skinner EC (2010) Extended lymphadenectomy in bladder cancer. Curr Opin Urol 20:414-420
26. Stein JP (2007) The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer. Curr Oncol Rep 9:213-221
27. Stein JP, Skinner DG (2004) Surgical atlas radical cystectomy. BJU Int 94:97-121
28. Roth B, Wissmayer MP, Zehnder P et al (2010) A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 57:205-211
29. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner R, Lerner SP (2004) Stage specific lymph node metastasis mapping in radical cystectomy specimen. J Urol 171:1830-1834
30. Abol-Enein H, El-Baz M, Abd-El-Hameed MA, Abdel-Latif M, Ghonheim MA (2004) Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study - a single center experience. J Urol 172:1818-1821
31. Leissner J, Ghoneim MA, Abol-Enein H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139-144
32. Seiler R, von Gunten M, Thlmann GN, Fleischmann A (2010) Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer. J Clin Pathol 63:504-507
33. Dorin RP, Daneshmand S, Skinner EC et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60:946-952
34. Rink M, Cha EK, Green D, Shariat SF et al (2012) Biomolecular Predictors of Urothelial Cancer Behavior and Treatment Outcomes. Curr Urol Rep 13(2):122-135
35. Burkhard FC, Roth B, Zehnder P, Studer UE (2011) Lymphadenectomy for bladder cancer: indications and controversies. Urol Clin North Am 38(4):397-405
36. Lerner SP, Skinner DG, Lieskovsky G et al (1993) The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long term results. J Urol 149:758-765
37. Vieweg J, Whitmore WF Jr, Herr HW et al (1994) The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan Kettering Cancer Center experience. Cancer 73:3020-3028
38. May M, Herrmann E, Bolenz C et al (2011) Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol 18:2018-2025
39. Herr HW, Faulkner JR, Grossmann HB et al (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22(14):2781-2789
40. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85:817-823
41. Simone G, Papalia R, Ferriero M, Guaglianone S, Castelli E, Collura D, Muto G, Gallucci M (2012) Stage specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. Int J Urol 20(4):1442-2042
42. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873-878
43. Rink M, Shariat SF, Xylinas E (2012) Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol 30(6):807-814
44. Tarin TV, Power NE, Bochner BH et al (2012) Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol 61:1025-1030
45. Kurahashi T, Hara I, Oka N, Kamidono S, Eto H, Miyake H (2005) Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res 11(10):3773-3777
46. Morgan T, Kaffenberger S, Cookson M (2012) Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer. J Urol 188:1081-1088
47. May M, Herrmann E, Bolenz C, Bastian PJ et al (2011) Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol 59(5):712-718
48. Stein JP, Penson DF, Cai J et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177:876-881
49. Shariat SF, Ehdaie B, Rink M et al (2012) Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol 61(2):237-242
50. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH (2006) Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 107(10):2368-2374
51. Karakiewicz PI, Shariat SF, Palapattu GS et al (2006) Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 176:1354-1362
52. Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 12:6663-6676
53. Brossner C, Pycha A, Toth A, Mian C, Kuber W (2004) Does extended pelvic lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 93:64-66
54. Rink M, Chun FK, Shariat SF et al (2012) Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies. Urologe A 51(6):820-828
55. Capitanio U, Suardi N, Shariat SF et al (2009) Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int 103:1359-1362